Medical Health & Life Science Research News

Global nocturia pipeline therapeutics review H2 2017 insights shared in detailed report

The Nocturia - Pipeline Review, H2 2017 report reviews latest news related to pipeline therapeutics for Nocturia (Genito Urinary System And Sex Hormones).

- Agency -.

The Nocturia pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

Nocturia Pipeline H2 2017, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape.

Get Nocturia Pipeline Review Report 2017@ www.reportsnreports.com/contacts/discount.aspx?name=1125838

Nocturia Companies Involved in Therapeutics Development : Astellas Pharma Inc, Ferring , International Center SA, Sanwa Kagaku Kenkyusho Co Ltd, Vantia Therapeutics, Nocturia - Drug Profiles

Nocturia - Drug Profiles : ASP-7035, ASP-7398, desmopressin acetate ODT, FE-201836, fedovapagon, SK-1404

Access Complete Report On Nocturia Pipeline Review, H2 2017: www.reportsnreports.com/purchase.aspx?name=1125838

Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons.

- Agency -.

Causes of nocturia include congestive heart failure, edema of lower extremities, sleeping disorders such as obstructive sleep apnea, certain drugs, including diuretics (water pills), cardiac glycosides, demeclocycline, lithium, methoxyflurane, phenytoin, propoxyphene, and excessive vitamin d and drinking too much fluid before bedtime, especially coffee, caffeinated beverages, or alcohol. Treatment includes anticholinergic medications.

Nocturia Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Nocturia (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Nocturia (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Nocturia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Phase I stages are 2, 3 and 2 respectively.

List of Figures
Number of Products under Development for Nocturia, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Targets, H2 2017
Number of Products by Stage and Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.